载脂蛋白A在高密度脂蛋白中所占比例与维持型腹膜透析患者腹膜溶质转运速率关系的研究
Investigation of the Relationship between the Proportion of Apolipoprotein A in High Den-sity Lipoprotein and the Rate of Peritoneal Solute Transport in Patients on Maintenance Dialysis
DOI: 10.12677/ACM.2023.131131, PDF,    科研立项经费支持
作者: 路 静, 高 洁, 孙 晶, 黄 倩, 张 耀, 钟 硕, 王海萍:山东第一医科大学附属省立医院肾内科,山东 济南
关键词: 高密度脂蛋白载脂蛋白A腹膜透析腹膜溶质转运速率High Density Lipoprotein Apolipoprotein A Peritoneal Dialysis Peritoneal Solute Transport Rate
摘要: 目的:分析载脂蛋白A (APOA)在高密度脂蛋白(HDL)中所占比例与维持性腹膜透析患者腹膜溶质转运速率(PSTR)相关性。方法:回顾性地选择2013年2月至2022年1月山东第一医科大学附属省立医院收治并行腹膜透析置管术的腹膜透析患者108例为研究对象,根据患者腹膜透析腹膜平衡实验D/P分为高转运组和低转运组,比较两组患者血脂水平、D/D0及超滤情况。对其中52例腹膜透析时间 > 24月的患者,比较患者透析3月与透析24月时D/P值、D/D0值、超滤量及血脂水平的变化,计算ΔAPOA、ΔAPOB、ΔAPOA/HDL、ΔAPOB/HDL值,分析各项数值变化与患者ΔD/P、ΔD/D0、超滤量变化的相关性。结果:低转运组与高转运组患者血清HDL、LDL、APOB、APOA、APOB/HDL、APOA/APOB、超滤水平比较差异无统计学意义(均p > 0.05),而高转运组患者D/D0及血清APOA/HDL水平低于低转运组,差异有统计学意义(p < 0.01)。进一步根据透析龄分析发现,在透析3月和透析12月时,低转运组血清APOA、APOA/HDL水平及超滤量均高于高转运组患者。自身前后结果对比显示,患者透析3月时血清APOA、APOA/HDL水平及超滤量均高于透析24月时,且患者透析3月与透析24月时ΔAPOA/HDL值与ΔD/P值呈负相关(r = −0.77, p < 0.01),与ΔD/D0值呈正相关(r = 0.35, p < 0.05),即APOA在HDL中所占比例低,患者D/P值高,D/D0值低,腹膜溶质转运率增加。结论:维持性腹膜透析患者血清APOA在HDL中所占比例与患者的腹膜溶质转运速率具有相关性,提示APOA是PD病人腹膜转运功能的保护性因素。
Abstract: Objective: To analyze the correlation between the proportion of Apolipoprotein A (APOA) in High-Density Lipoprotein (HDL) and the peritoneal solute transport rate (PSTR) in maintenance peritoneal dialysis patients. Methodology: A retrospective study was conducted on 108 patients on peritoneal dialysis catheterization admitted to a provincial hospital affiliated with Shandong First Medical University between February 2013 and January 2022. According to the peritoneal balance experiment D/P of patients with peritoneal dialysis, they were divided into high transport group and low transport group, and compare the blood lipid level, D/D0 and ultrafiltration of the two groups. For 52 patients with peritoneal dialysis time > 24 months, compare the changes of D/P val-ue, D/D0 value, ultrafiltration volume and blood lipid level between 3 months and 24 months of di-alysis, calculate ΔAPOA, ΔAPOB, ΔAPOA/HDL, ΔAPOB/HDL values, and analyze the correlation be-tween the changes of various values and the changes of ΔD/P, ΔD/D0, and ultrafiltration volume. Result: There was no significant difference in the levels of serum HDL, LDL, APOB, APOA, APOB/HDL, APOA/APOB and ultrafiltration between the low transport group and the high transport group (all p > 0.05), while the levels of D/D0 and serum APOA/HDL in the high transport group were lower than those in the low transport group (p < 0.01). Further analysis of dialysis age showed that the serum APOA, APOA/HDL and ultrafiltration volume levels in the low transport group were higher than those in the high transport group at 3 months and 12 months of dialysis. The comparison of the results before and after results showed that the levels of serum APOA, APOA/HDL and ultrafil-tration volume at 3 months of dialysis were higher than those at 24 months of dialysis, and the ΔAPOA/HDL values at 3 months and 24 months of dialysis were negatively correlated with ΔD/P values (r = −0.77, p < 0.01), and positively correlated with ΔD/D0 values (r = 0.35, p < 0.05), that is, the proportion of APOA in HDL was low, the patients’ D/P values were high, the D/D0 values were low, and the peritoneal solute transport rate increased. Conclusion: The proportion of serum APOA in HDL of maintenance peritoneal dialysis patients is correlated with the peritoneal solute transport rate of patients, suggesting that APOA is a protective factor of peritoneal transport function in PD patients.
文章引用:路静, 高洁, 孙晶, 黄倩, 张耀, 钟硕, 王海萍. 载脂蛋白A在高密度脂蛋白中所占比例与维持型腹膜透析患者腹膜溶质转运速率关系的研究[J]. 临床医学进展, 2023, 13(1): 904-913. https://doi.org/10.12677/ACM.2023.131131

参考文献

[1] Churchill, D.N., Thorpe, K.E., Nolph, K., et al. (1998) Increased Peritoneal Membrane Transport Is Associated with De-creased Patient and Technique Survival for Continuous Peritoneal Dialysis Patients. The Canada-USA (CANUSA) Peri-toneal Dialysis Study Group. Journal of the American Society of Nephrology, 9, 1285-1292. [Google Scholar] [CrossRef
[2] Rumpsfeld, M., McDonald, S.P. and Johnson, D.W. (2006) Higher Peritoneal Transport Status Is Associated with Higher Mortality and Technique Failure in the Australian and New Zea-land Peritoneal Dialysis Patient Populations. Journal of the American Society of Nephrology, 17, 271-278. [Google Scholar] [CrossRef
[3] Kon, M., Hirayama, S., Horiuchi, Y., et al. (2010) Profiles of In-flammatory Markers and Lipoprotein Subclasses in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis. Clinica Chimica Acta, 411, 1723-1727. [Google Scholar] [CrossRef] [PubMed]
[4] Attman, P.O., Samuelsson, O.G., Moberly, J., et al. (1999) Apolipoprotein B-Containing Lipoproteins in Renal Failure: The Relation to Mode of Dialysis. Kidney International, 55, 1536-1542. [Google Scholar] [CrossRef] [PubMed]
[5] Moberly, J.B., Attman, P.O., Samuelsson, O., et al. (2002) Alterations in Lipoprotein Composition in Peritoneal Dialysis Patients. Peritoneal Dialysis International, 22, 220-228. [Google Scholar] [CrossRef
[6] 孔媛媛, 薛志强, 严功辉, 等. 血脂异常对腹膜透析患者超滤衰竭的影响[J]. 中国医学创新, 2015, 12(10): 21-23.
[7] Zhan, X., Chen, Y., Yan, C., et al. (2018) Apolipoprotein B/Apolipoprotein A1 Ratio and Mortality among Incident Peritoneal Dialysis Patients. Lipids in Health and Disease, 17, 117. [Google Scholar] [CrossRef] [PubMed]
[8] Nadeau-Fredette, A.C., Chan, C.T., Cho, Y., et al. (2015) Outcomes of Integrated Home Dialysis Care: A Multi-Centre, Multi-National Registry Study. Nephrology Dialysis Transplantation, 30, 1897-1904. [Google Scholar] [CrossRef] [PubMed]
[9] Davies, S.J., Phillips, L., Griffiths, A.M., et al. (1998) What Really Hap-pens to People on Long-Term Peritoneal Dialysis? Kidney International, 54, 2207-2217. [Google Scholar] [CrossRef] [PubMed]
[10] Fusshoeller, A. (2008) Histomorphological and Functional Changes of the Peritoneal Membrane during Long-Term Peritoneal Dialysis. Pediatric Nephrology, 23, 19-25. [Google Scholar] [CrossRef] [PubMed]
[11] Teitelbaum, I. (2015) Ultrafiltration Failure in Peritoneal Dialysis: A Pathophysiologic Approach. Blood Purification, 39, 70-73. [Google Scholar] [CrossRef] [PubMed]
[12] Tanabe, K., Maeshima, Y., Ichinose, K., et al. (2007) Endostatin Peptide, an Inhibitor of Angiogenesis, Prevents the Progression of Peritoneal Sclerosis in a Mouse Experimental Model. Kidney International, 71, 227-238. [Google Scholar] [CrossRef] [PubMed]
[13] Cho, Y., Johnson, D.W., Vesey, D.A., et al. (2014) Dialysate Interleu-kin-6 Predicts Increasing Peritoneal Solute Transport Rate in Incident Peritoneal Dialysis Patients. BMC Nephrology, 15, 8. [Google Scholar] [CrossRef] [PubMed]
[14] Margetts, P.J., Kolb, M., Yu, L., et al. (2002) Inflammatory Cyto-kines, Angiogenesis, and Fibrosis in the Rat Peritoneum. The American Journal of Pathology, 160, 2285-2294. [Google Scholar] [CrossRef
[15] Jayne, D.G., Perry, S.L., Morrison, E., et al. (2000) Acti-vated Mesothelial Cells Produce Heparin-Binding Growth Factors: Implications for Tumour Metastases. British Journal of Cancer, 82, 1233-1238. [Google Scholar] [CrossRef] [PubMed]
[16] 钟慧, 苏白海, 邱红渝, 等. 不同腹膜转运特性的腹膜透析患者炎症和氧化应激状态的研究[J]. 中国实用内科杂志, 2007(11): 860-862.
[17] Liu, D., Ding, Z., Wu, M., et al. (2017) The Apolipoprotein A-I Mimetic Peptide, D-4F, Alleviates ox-LDL-Induced Oxidative Stress and Promotes Endothelial Repair through the eNOS/HO-1 Pathway. The Journal of Molecular and Cellular Cardiology, 105, 77-88. [Google Scholar] [CrossRef] [PubMed]
[18] Guo, Y., Li, W., Qian, M., et al. (2020) D-4F Ameliorates Con-trast Media-Induced Oxidative Injuries in Endothelial Cells via the AMPK/PKC Pathway. Frontiers in Pharmacology, 11, Article ID: 556074. [Google Scholar] [CrossRef] [PubMed]
[19] Navab, M., Imes, S.S., Hama, S.Y., et al. (1991) Monocyte Transmigration Induced by Modification of Low Density Lipoprotein in Cocultures of Human Aortic Wall Cells Is Due to Induction of Monocyte Chemotactic Protein 1 Synthesis and Is Abolished by High Density Lipoprotein. Journal of Clinical Investigation, 88, 2039-2046. [Google Scholar] [CrossRef
[20] Aroeira, L.S., Aguilera, A., Sanchez-Tomero, J.A., et al. (2007) Epithelial to Mesenchymal Transition and Peritoneal Membrane Failure in Peritoneal Dialysis Patients: Pathologic Significance and Potential Therapeutic Interventions. Journal of the American Society of Nephrology, 18, 2004-2013. [Google Scholar] [CrossRef
[21] 丘美兰, 陈勇平, 廖伟增, 等. 腹膜厚度与腹膜溶质转运功能的相关性[J]. 中华肾脏病杂志, 2020(3): 197-198.
[22] Lee, E., Lee, E.J., Kim, H., et al. (2013) Overexpression of Apolipoprotein A1 in the Lung Abrogates Fibrosis in Experimental Silicosis. PLOS ONE, 8, e55827. [Google Scholar] [CrossRef] [PubMed]
[23] Ho, A., Cheng, C., Lee, S., et al. (2010) Novel Biomarkers Pre-dict Liver Fibrosis in Hepatitis C Patients: Alpha 2 Macroglobulin, Vitamin D Binding Protein and Apolipoprotein AI. Journal of Biomedical Science, 17, 58. [Google Scholar] [CrossRef] [PubMed]